1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co. Ltd.
  6. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO. LTD.

(1099)
  Report
Delayed Hong Kong Stock Exchange  -  03:14 2022-07-05 am EDT
19.48 HKD   +0.83%
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
06/23Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, Payable No Later Than 23 August 2022
CI
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
06/28/2022 06/29/2022 06/30/2022 07/04/2022 07/05/2022 Date
19.02(c) 18.98(c) 19.02(c) 19.32(c) 19.48 Last
4 523 700 4 548 944 4 046 178 2 802 965 2 217 991 Volume
+2.59% -0.21% +0.21% +1.58% +0.83% Change
More quotes
Estimated financial data (e)
Sales 2022 576 B 85 924 M 85 924 M
Net income 2022 8 567 M 1 279 M 1 279 M
Net Debt 2022 22 148 M 3 305 M 3 305 M
P/E ratio 2022 5,99x
Yield 2022 4,74%
Sales 2023 640 B 95 457 M 95 457 M
Net income 2023 9 547 M 1 425 M 1 425 M
Net Debt 2023 18 860 M 2 815 M 2 815 M
P/E ratio 2023 5,38x
Yield 2023 5,19%
Capitalization 51 489 M 7 685 M 7 685 M
EV / Sales 2022 0,13x
EV / Sales 2023 0,11x
Nbr of Employees 113 234
Free-Float 43,0%
More Financials
Company
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical... 
Sector
Drug Retailers
Calendar
08/26Earnings Release
More about the company
Ratings of Sinopharm Group Co. Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about SINOPHARM GROUP CO. LTD.
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
06/23Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, ..
CI
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
06/17Sinopharm Group Co. Ltd. Announces Executive Changes
CI
06/10Sinopharm Group Co. Ltd. Announces Resignation of Deng Jindong as Member of Audit Commi..
CI
06/10ChromaDex Signs Tru Niagen Distribution Deal With Sinopharm Xingsha; Shares Climb Prema..
MT
06/02Sinopharm Group Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, ..
CI
05/19CanSino Biologics Rises After WHO Approves Covid Vaccine for Emergency Use
DJ
05/19ChromaDex Forming Joint Venture to Sell Tru Niagen Supplement in China; Shares Jump Alm..
MT
05/18Kanger International Ends Deal With Sinopharm Group Hunan Changde Medical; Kanger's Sha..
MT
04/27Chinese Shares Rebound Strongly; Sinopharm Jumps 6% on Clinical Trial Approval
MT
04/26Sinopharm Unit Wins Nod to Test Omicron Vaccine in China
MT
04/22Sinopharm Group's Attributable Profit Rises in Q1
MT
04/19Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31,..
CI
04/16Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial
RE
More news
News in other languages on SINOPHARM GROUP CO. LTD.
06/23Sinopharm Group Co., Ltd. approuve le dividende final pour l'année se terminant le 31 d..
06/17Sinopharm Group Co. Ltd. annonce des changements au niveau de la direction
06/10Sinopharm Group Co. Ltd. annonce la démission de Deng Jindong en tant que membre du com..
06/10ChromaDex signe un accord de distribution de Tru Niagen avec Sinopharm Xingsha ; les ac..
06/02Sinopharm Group Co., Ltd. Propose un dividende final pour l'année se terminant le 31 dé..
More news
Analyst Recommendations on SINOPHARM GROUP CO. LTD.
More recommendations
Chart SINOPHARM GROUP CO. LTD.
Duration : Period :
Sinopharm Group Co. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO. LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 16,50 CNY
Average target price 20,08 CNY
Spread / Average Target 21,7%
EPS Revisions
Managers and Directors
Yong Liu President & Executive Director
Xiao Juan Li Chief Financial Officer
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Wu Ping Tao Member-Supervisory Board